A/Prof Sanj Wickremasinghe
Clinical (Associate Professor)
Department of Surgery
95 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response – 6-month interim analysis of the FURGGHORN study
DOI: 10.1016/j.apjo.2026.1002992026
Journal article
Switching to Faricimab or High-Dose Aflibercept for Neovascular AMD in High-Demand Patients: Impact on Injection Interval in a Real-World Cohort
DOI: 10.1111/ceo.700992025
Journal article
Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema
DOI: 10.1155/joph/56370712024
Journal article
Elevated aqueous TNF-α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema
DOI: 10.1111/ceo.144252024
Journal article
Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancy
DOI: 10.1016/j.ajoc.2024.1020952024
Journal article
Clinical performance of predicting late age-related macular degeneration development using multimodal imaging
DOI: 10.1111/ceo.144052024
Journal article
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
DOI: 10.1007/s40123-024-00983-2
RECENT SCHOLARLY WORKS
2024
Journal article
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
DOI: 10.1016/j.ophtha.2024.02.0142024
Journal article
Fluorescein Angiogram Causing Cutaneous Venous Staining: A Rare Self-Resolving Phenomenon
DOI: 10.1159/0005399002023
Journal article
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
DOI: 10.1038/s41433-023-02525-9